Xencor (XNCR) EBIT (2013 - 2026)
Xencor's (XNCR) quarterly EBIT came in at -$77.9 million in Q1 2026, down 80.31% year-on-year from -$395.4 million in Q1 2025, and down 45.19% on a QoQ basis from -$53.6 million in Q4 2025.
Xencor (XNCR) EBIT (2013 - 2026) Analysis & Trends
Xencor (XNCR) has 14 years of EBIT data on file, last reported at -$77.9 million in Q1 2026.
- On a quarterly basis, EBIT fell 80.31% year-over-year to -$77.9 million in Q1 2026; TTM through Mar 2026 was -$212.2 million, a 27.11% decrease from a year earlier, with the FY2025 full-year figure at -$177.5 million, up 0.51% from the prior year.
- EBIT for Q1 2026 stood at -$77.9 million, down from -$53.6 million in the prior quarter.
- Over the last five years, EBIT for XNCR reached as high as $26.5 million in Q1 2022 and fell as low as -$77.9 million in Q1 2026.
- Historically, EBIT has averaged -$38.2 million across 5 years, with a median of -$42.6 million in 2022.
- On a YoY basis, EBIT climbed as much as 268.87% in 2022 and fell as far as 408.13% in 2022.
- Year by year, EBIT stood at -$42.6 million in 2022, then soared by 35.79% to -$27.4 million in 2023, then jumped by 51.82% to -$13.2 million in 2024, then plunged by 306.95% to -$53.6 million in 2025, then sank by 45.19% to -$77.9 million in 2026.
- Per Business Quant data, the three most recent EBIT figures were -$77.9 million in Q1 2026, -$53.6 million in Q4 2025, and -$47.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Xencor | 1.47 Bn | 1.09 Bn | - | -77.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -77.86 Mn |
| Dec 31, 2025 | -53.63 Mn |
| Sep 30, 2025 | -47.52 Mn |
| Jun 30, 2025 | -33.17 Mn |
| Mar 31, 2025 | -43.18 Mn |
| Dec 31, 2024 | -13.18 Mn |
| Sep 30, 2024 | -55.20 Mn |
| Jun 30, 2024 | -55.37 Mn |
| Mar 31, 2024 | -54.66 Mn |
| Dec 31, 2023 | -27.35 Mn |
| Sep 30, 2023 | -18.27 Mn |
| Jun 30, 2023 | -26.00 Mn |
| Mar 31, 2023 | -60.74 Mn |
| Dec 31, 2022 | -42.59 Mn |
| Sep 30, 2022 | -38.35 Mn |
| Jun 30, 2022 | -28.00 Mn |
| Mar 31, 2022 | 26.47 Mn |
| Dec 31, 2021 | 91.65 Mn |
| Sep 30, 2021 | -41.30 Mn |
| Jun 30, 2021 | 9.09 Mn |